Drug profile

The FDA adverse-event record for Multi-Vitamin

63 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Multi-Vitamin. See the species affected, top reactions, and outcomes below.

63
adverse-event reports
44.4%
death-coded share
Dog
most-reported species
16
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
63
Total Reports
28
Deaths Reported
44.4%
Death Rate

Active Ingredients

Multi-Vitamin

Administration Routes

UnknownOralSubcutaneousIntramuscularTopical

Species Affected

Dog 37
Cattle 23
Cat 2
Goat 1

Most Affected Breeds

Cattle (other) 9
Mixed (Cattle) 9
Retriever - Labrador 8
Terrier - Yorkshire 3
Aberdeen Angus 2
Red Angus 2
Retriever - Golden 2
Bichon Frise 2
Cattle (unknown) 1
Bulldog 1

Most Reported Reactions

Death 16
Lack of efficacy (bacteria) - NOS 12
Lethargy (see also Central nervous system depression in 'Neurological') 10
Lack of efficacy - NOS 9
Vomiting 8
Death by euthanasia 6
Behavioural disorder NOS 5
Anorexia 5
Diarrhoea 5
Other abnormal test result NOS 4
INEFFECTIVE, LOSS OF EFFECT 4
Anaphylactic-type reaction 4

Outcome Breakdown

Died
24 (27.9%)
Outcome Unknown
24 (27.9%)
Ongoing
19 (22.1%)
Recovered/Normal
9 (10.5%)
Euthanized
7 (8.1%)
Recovered with Sequela
3 (3.5%)

Multi-Vitamin Adverse Event Insights

63 reports name Multi-Vitamin; 28 recorded a death outcome (44.4% of reported events, not a population-level mortality rate). Active ingredient: Multi-Vitamin. Administration routes: Unknown, Oral, Subcutaneous, Intramuscular.

By species: Dog (37 reports), Cattle (23 reports), Cat (2 reports). By breed: Cattle (other) (9), Mixed (Cattle) (9), Retriever - Labrador (8).

Leading clinical signs: Death (16), Lack of efficacy (bacteria) - NOS (12), Lethargy (see also Central nervous system depression in 'Neurological') (10), Lack of efficacy - NOS (9). Outcome, 86 coded reports: Died leads at 27.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.